Reported Oct 29, 2025 · Ongoing
Bupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg, 30-count bottles, Rx Only, Mfd. by: Graviti…
Graviti Pharmaceuticals Private Limited
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Graviti Pharmaceuticals Private Limited · E & 621 Patancheru Mandal · Hyderabad · N/A
Is this the product you have?
- Bupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg, 30-count bottles, Rx Only, Mfd
- byGraviti Pharmaceuticals Private Limited, Sangareddy, Telangana, India, Dist
- byRising Phar, NDC 16571-863-03
- Lot codes and dates
- Batch # BPB124341A
- Exp date10/2026
- Amount recalled
- 46,512/30 count bottles
Where it was sold
- Nationwide
Why it was recalled
Failed Tablet/Capsule Specifications
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Graviti Pharmaceuticals Private Limited recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.